Acepodia is a clinical-stage biotechnology company developing first-in-class immune cell engagers with its unique Antibody-Cell Conjugation (ACC) platform technology to address oncology and autoimmune diseases.
IsomAb is developing isoform specific antibodies using a combined bioinformatics/knowledge-based platform approach to treat diseases where patients currently have limited treatment options.
MassBio Video
Mabylon AG is a Swiss biotechnology company harnessing the therapeutic potential of naturally occurring human antibodies to treat allergies, neurodegenerative diseases, and inflammation.
Mediar Therapeutics is a biotechnology company pioneering a new approach to fibrosis treatment that halts the disease at a different source – the fibrotic mediators that drive disease progression.
